Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.510
-0.220 (-8.06%)
Aug 1, 2025, 4:00 PM - Market closed
Accolade Market Cap
Annovis Bio has a market cap or net worth of $48.91 million as of August 1, 2025. Its market cap has decreased by -64.86% in one year.
Market Cap
48.91M
Enterprise Value
26.67M
1-Year Change
-64.86%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $48.91M, a decrease of -21.75%. That is a compound annual growth rate of -4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 48.91M | -29.52% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |